RXST
RXST
NASDAQ · Health Care

Rxsight Inc

$5.61
+0.44 (+8.51%)
As of Jul 4, 10:30 PM ET ·
Financial Highlights (FY 2026)
Revenue
143.44M
Net Income
-41,536,513
Gross Margin
76.6%
Profit Margin
-29.0%
Rev Growth
+40.0%
D/E Ratio
0.00
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 76.6% 76.6% 56.0% 56.0%
Operating Margin -35.8% -32.3% 19.2% 20.8%
Profit Margin -29.0% -27.5% 16.8% 12.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 143.44M 102.45M 45.49M 50.58M
Gross Profit 109.87M 78.48M 25.48M 28.33M
Operating Income -51,407,711 -33,047,814 8.73M 10.51M
Net Income -41,536,513 -26,702,044 7.66M 6.55M
Gross Margin 76.6% 76.6% 56.0% 56.0%
Operating Margin -35.8% -32.3% 19.2% 20.8%
Profit Margin -29.0% -27.5% 16.8% 12.9%
Rev Growth +40.0% +40.0% +1.5% +13.9%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 34.8K 34.8K 28.42M 28.12M
Total Equity 116.08M 116.08M 288.95M 248.82M
D/E Ratio 0.00 0.00 0.10 0.11
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -51,366,196 -34,855,633 11.61M 13.24M
Free Cash Flow 5.18M 4.95M